We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > RBD

News List

Antibody Response to SARS-CoV-2 Wanes Among Dialysis Patients Drugs
December 16, 2021
For persons receiving dialysis, the antibody response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) wanes through five to six months and is associated with a risk for breakthrough infection...
A protein-based COVID-19 vaccine that mimics the shape of the virus worldpharmanews
August 13, 2021
Even as several safe and effective COVID-19 vaccines are being administered to people worldwide, scientists are still hard at work developing different vaccine strategies that could provide even stronger or longer-lasting immunity against SARS-CoV-2 ...
Our immune systems blanket the SARS-CoV-2 spike protein with antibodies worldpharmanews
May 11, 2021
The most complete picture yet is coming into focus of how antibodies produced in people who effectively fight off SARS-CoV-2 work to neutralize the part of the virus responsible for causing infection. In the journal Science, researchers at ...
Axovant dumps nelotanserin in retreat from small molecule R&D fiercebiotech
December 28, 2018
Axovant has halted development of nelotanserin after it missed the primary endpoint in a phase 2 trial in patients with Lewy body dementia.....